The UroLift implant: mechanism behind rapid and durable relief from prostatic obstruction.

Claus G RoehrbornPeter T Chin Henry H Woo

Published in: Prostate cancer and prostatic diseases (2021)

These studies reveal the lack of impact the device has on systemic tissue, providing evidence that the UroLift System is benign and biocompatible, and offering histologic explanation for the clinically observed durability.

Keyphrases

genome wide
benign prostatic hyperplasia
single cell
soft tissue
ionic liquid
radical prostatectomy
case control
prostate cancer
loop mediated isothermal amplification
gene expression
drug delivery
dna methylation
quantum dots
sensitive detection